No Picture
Trading Ideas

UPDATE 1-Eli Lilly's migraine treatment wins U.S. FDA approval

The U.S. Food and Drug Administration said on Friday it had approved Eli Lilly and Co’s migraine drug, Reyvow. The drug has been approved to treat acute migraine with or without aura, a sensory phenomenon or visual disturbance, in adults. Lilly acquired Reyvow, formerly called lasmiditan, in a deal https://www.reuters.com/article/us-colucid-pharms-m-a-eli-lilly-idUSKBN1521O6 worth about $960 million when it bought CoLucid Pharmaceuticals Inc in early 2017. …read more […]

No Picture
Trading Ideas

Boeing and FAA failed to properly review 737 max system

Boeing is under fire yet again after a new report from a panel of international air safety regulators will reportedly criticize the FAA’s review of Boeing’s 737 max jet. The report also faults Boeing for not improving the airplane’s design. CFRA’s Jim Corridore joins Yahoo Finance’s Akiko Fujita to discuss. …read more […]

No Picture
Trading Ideas

Hedge Funds Have Never Been This Bullish On Realty Income Corporation (O)

There are several ways to beat the market, and investing in small cap stocks has historically been one of them. We like to improve the odds of beating the market further by examining what famous hedge fund operators such as Jeff Ubben, George Soros and Carl Icahn think. Those hedge fund operators make billions of […] …read more […]

No Picture
Trading Ideas

Hedge Funds Have Never Been Less Bullish On HP Inc. (HPQ)

We at Insider Monkey have gone over 730 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds’ and investors’ portfolio positions as of June 28th. In this article, we look at what those funds think of HP Inc. (NYSE:HPQ) based on that data. […] …read more […]